https://scholars.lib.ntu.edu.tw/handle/123456789/605766
標題: | BI-2536 Promotes Neuroblastoma Cell Death via Minichromosome Maintenance Complex Components 2 and 10 | 作者: | Hsieh, Chiao-Hui Yeh, Hsiang-Ning Huang, Chen-Tsung Wang, Wei-Hsuan WEN-MING HSU Huang, Hsuan-Cheng HSUEH-FEN JUAN |
關鍵字: | BI-2536; cell death; minichromosome maintenance complex 2 and 10; mitochondria fusion; neuroblastoma | 公開日期: | 28-十二月-2021 | 出版社: | MDPI | 卷: | 15 | 期: | 1 | 來源出版物: | Pharmaceuticals (Basel, Switzerland) | 摘要: | DNA replication is initiated with the recognition of the starting point of multiple replication forks by the origin recognition complex and activation of the minichromosome maintenance complex 10 (MCM10). Subsequently, DNA helicase, consisting of the MCM protein subunits MCM2-7, unwinds double-stranded DNA and DNA synthesis begins. In previous studies, replication factors have been used as clinical targets in cancer therapy. The results showed that MCM2 could be a proliferation marker for numerous types of malignant cancer. We analyzed samples obtained from patients with neuroblastoma, revealing that higher levels of MCM2 and MCM10 mRNA were associated with poor survival rate. Furthermore, we combined the results of the perturbation-induced reversal effects on the expression levels of MCM2 and MCM10 and the sensitivity correlation between perturbations and MCM2 and MCM10 from the Cancer Therapeutics Response Portal database. Small molecule BI-2536, a polo-like kinase 1 (PLK-1) inhibitor, is a candidate for the inhibition of MCM2 and MCM10 expression. To test this hypothesis, we treated neuroblastoma cells with BI-2536. The results showed that the drug decreased cell viability and reduced the expression levels of MCM2 and MCM10. Functional analysis further revealed enrichments of gene sets involved in mitochondria, cell cycle, and DNA replication for BI-2536-perturbed transcriptome. We used cellular assays to demonstrate that BI-2536 promoted mitochondria fusion, G2/M arrest, and apoptosis. In summary, our findings provide a new strategy for neuroblastoma therapy with BI-2536. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/605766 | ISSN: | 1424-8247 | DOI: | 10.3390/ph15010037 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。